所以在对CKD人群使用他汀类药物进 行CVD—、二级预防时,一定要考虑患者的肾功能情况,选择合适的药物和剂量, 避免药物的不良反应。 五、总结 NICE于2023年颁布的《心血管疾病风险评估与降低,包括脂质调节》主要 对CVD风险评估工具、生活方式改变、阿司匹林、他汀类药物使用等内容进行了 更新,对我国CVD预防提供了新的...
View this table: Table 1 Classification of chronic kidney disease (CKD) in adults, and risk of adverse outcomes by category In August 2021, the National Institute for Health and Care Excellence (NICE) published NG203,2 an updated and combined version of three guidelines: "chronic kidney ...
Re: Early identification and management of chronic kidney disease in adults: summary of updated NICE guidance Nijmegen, 4 August 2014 Dear authors, We welcome the publication of the updated NICE guideline on early identification and management of chronic kidney disease (CKD) in adults, which provid...
所以在对CKD人群使用他汀类药进 行CVD—、二级预防时,一定要考虑患者的肾功能情况,选择合适的药和剂量, 避免药的不良反应。 五、总结 NICE于2023年颁布的《心血管疾病风险评估与降低,包括脂质调节》主要 对CVD风险评估工具、生活方式改变、阿司匹林、他汀类药使用等内容进行了 更新,对我国CVD预防提供了新的指导。但...
The article offers summary of National Institute for Health and Clinical Excellence (NICE) recommendations on the diagnosis and management of headaches in young people and adults. It mentions that many clinicians in primary and secondary care find difficult to cure headaches. It is inclusive of ...